The Economist | Private share sales: Trading places https://t.co/i6xKQZB3Ai — The Propell Group (@ThePropellGroup) August 19, 2016 #healthtech
The Economist | Rare diseases: Fixing fate https://t.co/rguFWxDDMA — The Propell Group (@ThePropellGroup) August 19, 2016 #healthtech
Adding ages https://t.co/DnLaJSMdvj — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
The value of local lessons in tackling global killer diseases https://t.co/pqaZSiHfDl via @FT — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
Cheating death https://t.co/qn6eS2mEZJ — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
Will embryonic stem cells ever cure anything? https://t.co/0ppYW91aYO — The Propell Group (@ThePropellGroup) August 17, 2016 #healthtech
Stretchy electronics give artificial hands real feeling https://t.co/MNo38GYLdV — The Propell Group (@ThePropellGroup) August 17, 2016 #healthtech
Frontier Medicine: GE Acquires Biosafe to Advance Cell Therapy – GE Reports https://t.co/YJOVBFRCFM
0 0
Frontier Medicine: GE Acquires Biosafe to Advance Cell Therapy – GE Reports https://t.co/YJOVBFRCFM — The Propell Group (@ThePropellGroup) August 16, 2016 #healthtech
Frontier Medicine: GE Acquires Biosafe to Advance Cell Therapy – GE Reports https://t.co/AnQ4UNoqXs
0 0
Frontier Medicine: GE Acquires Biosafe to Advance Cell Therapy – GE Reports https://t.co/AnQ4UNoqXs — The Propell Group (@ThePropellGroup) August 16, 2016 #healthtech
Bugs in the system https://t.co/p6OJuNYUjQ — The Propell Group (@ThePropellGroup) August 15, 2016 #healthtech